Results for previously untreated patients translation from English to Maltese

previously untreated patients
pazjenti li ma kienux ħadu kura qabel

previously untreated patients:
pazjenti adulti li ma ġewx ikkurati qabel:

previously untreated cll:
cll mhux ikkurata minn qabel:

virological response in previously untreated paediatric patients
rispons viroloġiku f’pazjenti pedjatriċi li ma kienux ikkurati qabel.

patients previously untreated for cll
pazjenti li ma kinux ittrattati qabel għal cll

previously untreated mantle cell lymphoma
limfoma taċ-ċelluli mantle li qatt ma kienet ittrattat qabel

treatment emergent resistance in previously untreated patients failing therapy
reżistenza emerġenti għall-kura f’pazjenti mhux ikkurati qabel li l-kura ma rnexxietx fuqhom

zevalin is also used in previously untreated patients with follicular lymphoma.
zevalin jintuża wkoll f’pazjenti b’limfoma follikulari li ma kienux ikkurati minn qabel.

for the previously untreated patients, 6 out of 7 responded to treatment.
għall- pazjenti li kienu kkurati qabel, 6 minn 7 rrispondew għall-kura.

pharmacokinetic data with advate on previously untreated patients are currently not available.
attwalment m' hemmx tagħrif farmakokinetiku disponibbli dwar advate fuq pazjenti li ma kinux ġew ikkurati qabel.

results from the phase iii study (no25026) in previously untreated patients
riżultati mill-istudju ta’ fażi iii (no25026) f’pazjenti li ma kinux ikkurati qabel

there is no experience of the treatment of previously untreated patients with nonafact.
ma hemm ebda esperjenza dwar il-kura ta’ pazjenti li ma kienux qabel trattati b’nonafact.

there are no clinical data on previously untreated patients (pups) with refacto af.
17 m’ hemm l- ebda dejta klinika dwar pazjenti li ma kinux ikkurati qabel (pups) b’ refacto af.

previously untreated patients (results from the phase iii study [break-3])
il-pazjenti li ma ġewx ikkurati qabel (riżultati mill-istudju tal-fażi iii [break 3])

table 8 efficacy in previously untreated patients (break-3 study, 25 june 2012)
tabella 8 effikaċja f’pazjenti li ma ġewx ikkurati qabel (studju tal-break-3, 25 ta’ Ġunju 2012)

pups = previously untreated patients ptps = previously treated patients mtps = minimally treated patients
pups = pazjenti li ma ġewx ikkurati fil-passat ptps = pazjenti li ġew ikkurati fil-passat mtps = pazjenti kkurati minimament

there are insufficient data to provide information on inhibitor incidence in previously untreated patients (pups).
m’ hemmx biżżejjed informazzjoni sabiex jiġi fornut tagħrif fuq l- inċidenza ta ’ l- impeditur fil- pazjenti li ma kienux ikkurati qabel.

another study in 80 previously untreated patients compared vectibix and folfiri with vectibix in combination with folfox.
studju ieħor fi 80 pazjent li ma kinux ikkurati qabel qabbel vectibix u folfiri ma' vectibix flimkien ma' folfox.

153 obtained from ongoing clinical studies on the treatment of previously untreated patients (pups), with benefix.
144 studji kliniċi li għadhom għaddejjin dwar il- kura ta ’ pazjenti mhux kkurati qabel (previously untreated patients - pups), b’ benefix.

the first study involved previously untreated patients while the second study involved patients who had failed previous treatment.
l-ewwel studju involva pazjenti li ma ġewx ittrattati qabel filwaqt li t-tieni studju involva pazjenti li ma rnexxilhomx it-trattament.